OVID vs TFX · rev $733.0K vs P/E 2083, rev $1.12B
Ovid Therapeutics Inc (OVID) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
OVID currently screens at market cap $23.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the OVID and TFX stock pages for the full models.
Not investment advice.